AI English summary of an SEC filing — figures as filed
HCA Healthcare HCAHCA Healthcare said revenues for Q2 2025 totaled $18.605 billion, up 6.4% from $17.492 billion in the prior-year period, and net income attributable to HCA Healthcare, Inc. was $1.653 billion, or $6.83 per diluted share.
Key points
AI summaryHCA Healthcare said revenues for Q2 2025 totaled $18.605 billion, up 6.4% from $17.492 billion in the prior-year period, and net income attributable to HCA Healthcare, Inc. was $1.653 billion, or $6.83 per diluted share.
The company attributed the consolidated revenue increase for Q2 primarily to the combined impact of a 3.9% increase in revenue per equivalent admission and a 2.3% increase in equivalent admissions. On a same facility basis, revenue per equivalent admission and equivalent admissions increased 4.0% and 1.7%, respectively.
HCA Healthcare said cash provided by operating activities for the first six months of 2025 totaled $5.861 billion, up $1.421 billion from $4.440 billion in the prior-year period. The company cited an increase in net income of $392 million, excluding the non-cash impact of losses and gains on sales of facilities, and a decline in income taxes paid of $853 million as the primary factors.
During financing activities in the first six months of 2025, HCA Healthcare repurchased shares for $5.011 billion and paid dividends of $351 million, while debt increased by a net $1.341 billion. Total debt as of June 30, 2025 was $44.483 billion.
Key figures
Quarter ended June 30, 2025
- Revenue
- $18.6B
- Net income
- $1.7B
- EPS
- $6.83
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Q2 revenues $18.605 billion, net income $1.653 billion
HCA Healthcare said revenues for Q2 2025 totaled $18.605 billion, up 6.4% from $17.492 billion in the prior-year period, and net income attributable to HCA Healthcare, Inc. was $1.653 billion, or $6.83 per diluted share.
Source · Based on the MD&A text of the filing
Revenue increase attributed to higher revenue per equivalent admission and equivalent admissions
The company attributed the consolidated revenue increase for Q2 primarily to the combined impact of a 3.9% increase in revenue per equivalent admission and a 2.3% increase in equivalent admissions. On a same facility basis, revenue per equivalent admission and equivalent admissions increased 4.0% and 1.7%, respectively.
Source · Based on the MD&A text of the filing
First-half operating cash flow $5.861 billion
HCA Healthcare said cash provided by operating activities for the first six months of 2025 totaled $5.861 billion, up $1.421 billion from $4.440 billion in the prior-year period. The company cited an increase in net income of $392 million, excluding the non-cash impact of losses and gains on sales of facilities, and a decline in income taxes paid of $853 million as the primary factors.
Source · Based on the MD&A text of the filing
First-half share repurchases $5.011 billion, debt at end of June $44.483 billion
During financing activities in the first six months of 2025, HCA Healthcare repurchased shares for $5.011 billion and paid dividends of $351 million, while debt increased by a net $1.341 billion. Total debt as of June 30, 2025 was $44.483 billion.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…